Jyoti Malhotra
Rutgers, The State University of New Jersey
H-index: 26
North America-United States
Top articles of Jyoti Malhotra
Management of KRAS-Mutated Non–Small Cell Lung Cancer
2024/3
Jyoti Malhotra
H-Index: 17
A phase 1 study of fianlimab (anti-LAG-3) in combination with cemiplimab (anti-PD-1) in patients with advanced ccRCC.
2024/2/1
Miso Kim
H-Index: 12
Jyoti Malhotra
H-Index: 17
Fang Fang
H-Index: 36
Shuquan Chen
H-Index: 5
Karl Lewis
H-Index: 39
Integrating Early-Stage Drug Development with Clinical Networks; Challenges and Opportunities: The City of Hope Developing Experience
2023/6/15
Characteristics and predictive modeling of HER2 mutation in patients with non-small cell lung cancer.
2023/6/1
Garima Mittal
H-Index: 11
Kaushal Parikh
H-Index: 14
Jyoti Malhotra
H-Index: 17
Wenjin Chen
H-Index: 0
Dantong Yu
H-Index: 16
Pneumonitis in advanced non-small cell lung cancer: no interaction between immune checkpoint inhibition and radiation therapy
Journal of Thoracic Disease
2023/5/5
Jyoti Malhotra
H-Index: 17
Autophagy and MEK inhibition promotes ferroptosis in liver kinase B1 (Lkb1)-deficient Kras-driven lung tumors
Cancer Research
2023/4/4
Enrique Lopez
H-Index: 6
Xiaoyang Su
H-Index: 19
Jyoti Malhotra
H-Index: 17
Eileen White
H-Index: 62
Jessie Yanxiang Guo
H-Index: 17
Inhibition of autophagy and MEK promotes ferroptosis in Lkb1-deficient Kras-driven lung tumors
Cell Death & Disease
2023/1/26
Enrique Lopez
H-Index: 6
Xiaoyang Su
H-Index: 19
Jyoti Malhotra
H-Index: 17
Eileen White
H-Index: 62
Jessie Yanxiang Guo
H-Index: 17
A systems biology approach for addressing cisplatin resistance in non-small cell lung cancer
Journal of Clinical Medicine
2023/1
A phase I trial of riluzole and sorafenib in patients with advanced solid tumors: CTEP# 8850
Oncotarget
2023
Oncolytic viruses and cancer immunotherapy
2023/1
Jyoti Malhotra
H-Index: 17
603 Phase II trial of plinabulin in combination with nivolumab and ipilimumab in patients with recurrent small cell lung cancer (SCLC): big ten cancer research consortium …
2023/11/1
Jyoti Malhotra
H-Index: 17
602 A phase I trial of atezolizumab and varlilumab in combination with radiation in patients with metastatic non-small cell lung cancer (NSCLC)
2023/11/1
A Nexus between Genetic and Non-Genetic Mechanisms Guides KRAS Inhibitor Resistance in Lung Cancer
Biomolecules
2023/10/28
Efficacy and safety of anti-programmed cell death protein 1 antibody combination therapy in patients with advanced experienced epidermal growth factor receptor-tyrosine kinase …
Journal of Thoracic Disease
2023/10/10
Chang Wan
H-Index: 6
Gang Cheng
H-Index: 33
Sheng Chen
H-Index: 4
Jianping Xu
H-Index: 32
Jyoti Malhotra
H-Index: 17
Racial disparities in follow-up care of early-stage lung cancer survivors
Journal of Cancer Survivorship
2023/10
A phase I study of veliparib with cyclophosphamide and veliparib combined with doxorubicin and cyclophosphamide in advanced malignancies
Cancer chemotherapy and pharmacology
2022/1/1
Ectopic clotting factor VIII expression and misfolding in hepatocytes as a cause for hepatocellular carcinoma
Molecular Therapy
2022/12/7
A phase I study of talazoparib (BMN 673) combined with carboplatin and paclitaxel in patients with advanced solid tumors (NCI9782)
Cancer Medicine
2022/11
Addressing drug resistance in cancer: a team medicine approach
Journal of Clinical Medicine
2022/9/27
Sravani Ramisetty
H-Index: 3
Sandeep Mittan
H-Index: 3
Jyoti Malhotra
H-Index: 17
Naveen Gupta
H-Index: 1
Sagun Shrestha
H-Index: 3
Inhibition of Mtorc1/2 and DNA-PK via CC-115 Synergizes with Carboplatin and Paclitaxel in Lung Squamous Cell Carcinoma
Molecular cancer therapeutics
2022/9/6
Jyoti Malhotra
H-Index: 17
Tamara Minko
H-Index: 40
